XOMA ROYALTY CORP - XOMA 8 5/8 PERP (XOMAP) Fundamental Analysis & Valuation

NASDAQ:XOMAP • US98419J3059

Current stock price

27.25 USD
+0.77 (+2.91%)
Last:

This XOMAP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. XOMAP Profitability Analysis

1.1 Basic Checks

  • In the past year XOMAP was profitable.
  • In the past year XOMAP had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: XOMAP reported negative net income in multiple years.
  • In multiple years XOMAP reported negative operating cash flow during the last 5 years.
XOMAP Yearly Net Income VS EBIT VS OCF VS FCFXOMAP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M

1.2 Ratios

  • XOMAP's Return On Assets of 6.80% is amongst the best of the industry. XOMAP outperforms 92.07% of its industry peers.
  • XOMAP has a Return On Equity of 17.83%. This is amongst the best in the industry. XOMAP outperforms 94.58% of its industry peers.
  • XOMAP's Return On Invested Capital of 3.78% is amongst the best of the industry. XOMAP outperforms 89.36% of its industry peers.
Industry RankSector Rank
ROA 6.8%
ROE 17.83%
ROIC 3.78%
ROA(3y)-7.23%
ROA(5y)-6.6%
ROE(3y)-19.31%
ROE(5y)-14.1%
ROIC(3y)N/A
ROIC(5y)N/A
XOMAP Yearly ROA, ROE, ROICXOMAP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 400 600 800 1K

1.3 Margins

  • With an excellent Profit Margin value of 35.54%, XOMAP belongs to the best of the industry, outperforming 95.94% of the companies in the same industry.
  • XOMAP's Profit Margin has improved in the last couple of years.
  • The Operating Margin of XOMAP (21.83%) is better than 93.81% of its industry peers.
  • XOMAP's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 21.83%
PM (TTM) 35.54%
GM N/A
OM growth 3YN/A
OM growth 5Y-12.38%
PM growth 3YN/A
PM growth 5Y2.98%
GM growth 3YN/A
GM growth 5YN/A
XOMAP Yearly Profit, Operating, Gross MarginsXOMAP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. XOMAP Health Analysis

2.1 Basic Checks

  • XOMAP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, XOMAP has less shares outstanding
  • Compared to 5 years ago, XOMAP has more shares outstanding
  • The debt/assets ratio for XOMAP has been reduced compared to a year ago.
XOMAP Yearly Shares OutstandingXOMAP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
XOMAP Yearly Total Debt VS Total AssetsXOMAP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • Based on the Altman-Z score of -4.41, we must say that XOMAP is in the distress zone and has some risk of bankruptcy.
  • XOMAP has a Altman-Z score of -4.41. This is in the lower half of the industry: XOMAP underperforms 60.35% of its industry peers.
  • XOMAP has a debt to FCF ratio of 37.96. This is a negative value and a sign of low solvency as XOMAP would need 37.96 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 37.96, XOMAP belongs to the best of the industry, outperforming 89.17% of the companies in the same industry.
  • XOMAP has a Debt/Equity ratio of 0.93. This is a neutral value indicating XOMAP is somewhat dependend on debt financing.
  • XOMAP's Debt to Equity ratio of 0.93 is on the low side compared to the rest of the industry. XOMAP is outperformed by 74.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 37.96
Altman-Z -4.41
ROIC/WACC0.38
WACC9.96%
XOMAP Yearly LT Debt VS Equity VS FCFXOMAP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 3.37 indicates that XOMAP has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.37, XOMAP is in line with its industry, outperforming 41.01% of the companies in the same industry.
  • A Quick Ratio of 3.37 indicates that XOMAP has no problem at all paying its short term obligations.
  • XOMAP has a Quick ratio (3.37) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.37
Quick Ratio 3.37
XOMAP Yearly Current Assets VS Current LiabilitesXOMAP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. XOMAP Growth Analysis

3.1 Past

  • XOMAP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 170.87%, which is quite impressive.
  • XOMAP shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 29.56% yearly.
  • XOMAP shows a strong growth in Revenue. In the last year, the Revenue has grown by 73.96%.
  • XOMAP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.15% yearly.
EPS 1Y (TTM)170.87%
EPS 3YN/A
EPS 5Y29.56%
EPS Q2Q%157.78%
Revenue 1Y (TTM)73.96%
Revenue growth 3Y105.26%
Revenue growth 5Y12.15%
Sales Q2Q%57.87%

3.2 Future

  • Based on estimates for the next years, XOMAP will show a decrease in Earnings Per Share. The EPS will decrease by -8.80% on average per year.
  • XOMAP is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 32.50% yearly.
EPS Next Y-78.46%
EPS Next 2Y-8.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year28.91%
Revenue Next 2Y11.05%
Revenue Next 3Y18.11%
Revenue Next 5Y32.5%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XOMAP Yearly Revenue VS EstimatesXOMAP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M
XOMAP Yearly EPS VS EstimatesXOMAP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6 -8 -10

More info and screens

Find the best growth stocksShow best growing peers

5

4. XOMAP Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 18.66, the valuation of XOMAP can be described as rather expensive.
  • Based on the Price/Earnings ratio, XOMAP is valued cheaper than 93.81% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of XOMAP to the average of the S&P500 Index (26.91), we can say XOMAP is valued slightly cheaper.
  • The Price/Forward Earnings ratio is 86.67, which means the current valuation is very expensive for XOMAP.
  • Based on the Price/Forward Earnings ratio, XOMAP is valued cheaper than 88.39% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.69, XOMAP is valued quite expensively.
Industry RankSector Rank
PE 18.66
Fwd PE 86.67
XOMAP Price Earnings VS Forward Price EarningsXOMAP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of XOMAP indicates a rather cheap valuation: XOMAP is cheaper than 91.88% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of XOMAP indicates a rather cheap valuation: XOMAP is cheaper than 90.33% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 117.5
EV/EBITDA 24.6
XOMAP Per share dataXOMAP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • The decent profitability rating of XOMAP may justify a higher PE ratio.
  • A cheap valuation may be justified as XOMAP's earnings are expected to decrease with -8.80% in the coming years.
PEG (NY)N/A
PEG (5Y)0.63
EPS Next 2Y-8.8%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. XOMAP Dividend Analysis

5.1 Amount

  • XOMAP has a Yearly Dividend Yield of 8.14%, which is a nice return.
  • XOMAP's Dividend Yield is rather good when compared to the industry average which is at 1.11. XOMAP pays more dividend than 99.61% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, XOMAP pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.14%

5.2 History

  • XOMAP has been paying a dividend for over 5 years, so it has already some track record.
  • XOMAP has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years4
XOMAP Yearly Dividends per shareXOMAP Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • XOMAP pays out 29.53% of its income as dividend. This is a sustainable payout ratio.
DP29.53%
EPS Next 2Y-8.8%
EPS Next 3YN/A
XOMAP Yearly Income VS Free CF VS DividendXOMAP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M
XOMAP Dividend Payout.XOMAP Dividend Payout, showing the Payout Ratio.XOMAP Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

XOMAP Fundamentals: All Metrics, Ratios and Statistics

XOMA ROYALTY CORP - XOMA 8 5/8 PERP

NASDAQ:XOMAP (4/9/2026, 10:10:35 AM)

27.25

+0.77 (+2.91%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-18
Earnings (Next)04-30
Inst Owners70.51%
Inst Owner ChangeN/A
Ins Owners1.79%
Ins Owner ChangeN/A
Market Cap337.36M
Revenue(TTM)52.15M
Net Income(TTM)18.53M
Analysts81.82
Price Target67.19 (146.57%)
Short Float %0%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield 8.14%
Yearly Dividend0.46
Dividend Growth(5Y)N/A
DP29.53%
Div Incr Years0
Div Non Decr Years4
Ex-Date04-02
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1040.07%
Min EPS beat(2)264.45%
Max EPS beat(2)1815.69%
EPS beat(4)4
Avg EPS beat(4)623.83%
Min EPS beat(4)119.7%
Max EPS beat(4)1815.69%
EPS beat(8)5
Avg EPS beat(8)324.56%
EPS beat(12)6
Avg EPS beat(12)211.09%
EPS beat(16)7
Avg EPS beat(16)137.03%
Revenue beat(2)1
Avg Revenue beat(2)1.01%
Min Revenue beat(2)-20.06%
Max Revenue beat(2)22.07%
Revenue beat(4)3
Avg Revenue beat(4)38.88%
Min Revenue beat(4)-20.06%
Max Revenue beat(4)120.82%
Revenue beat(8)6
Avg Revenue beat(8)25.22%
Revenue beat(12)7
Avg Revenue beat(12)14.07%
Revenue beat(16)8
Avg Revenue beat(16)2.21%
PT rev (1m)0%
PT rev (3m)-2.38%
EPS NQ rev (1m)126.32%
EPS NQ rev (3m)126.32%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)1.32%
Revenue NQ rev (3m)1.32%
Revenue NY rev (1m)-0.28%
Revenue NY rev (3m)-4.64%
Valuation
Industry RankSector Rank
PE 18.66
Fwd PE 86.67
P/S 6.47
P/FCF 117.5
P/OCF 117.5
P/B 3.25
P/tB 5.7
EV/EBITDA 24.6
EPS(TTM)1.46
EY5.36%
EPS(NY)0.31
Fwd EY1.15%
FCF(TTM)0.23
FCFY0.85%
OCF(TTM)0.23
OCFY0.85%
SpS4.21
BVpS8.4
TBVpS4.78
PEG (NY)N/A
PEG (5Y)0.63
Graham Number16.61
Profitability
Industry RankSector Rank
ROA 6.8%
ROE 17.83%
ROCE 4.79%
ROIC 3.78%
ROICexc 5.82%
ROICexgc 8.19%
OM 21.83%
PM (TTM) 35.54%
GM N/A
FCFM 5.51%
ROA(3y)-7.23%
ROA(5y)-6.6%
ROE(3y)-19.31%
ROE(5y)-14.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-24.81%
ROICexc growth 3YN/A
ROICexc growth 5Y-29.78%
OM growth 3YN/A
OM growth 5Y-12.38%
PM growth 3YN/A
PM growth 5Y2.98%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 37.96
Debt/EBITDA 6.72
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage 0.96
Cash Conversion 20%
Profit Quality 15.49%
Current Ratio 3.37
Quick Ratio 3.37
Altman-Z -4.41
F-Score7
WACC9.96%
ROIC/WACC0.38
Cap/Depr(3y)3117.3%
Cap/Depr(5y)4643.1%
Cap/Sales(3y)23.75%
Cap/Sales(5y)64.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)170.87%
EPS 3YN/A
EPS 5Y29.56%
EPS Q2Q%157.78%
EPS Next Y-78.46%
EPS Next 2Y-8.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)73.96%
Revenue growth 3Y105.26%
Revenue growth 5Y12.15%
Sales Q2Q%57.87%
Revenue Next Year28.91%
Revenue Next 2Y11.05%
Revenue Next 3Y18.11%
Revenue Next 5Y32.5%
EBIT growth 1Y191.25%
EBIT growth 3YN/A
EBIT growth 5Y-1.73%
EBIT Next Year117.22%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y108.46%
FCF growth 3YN/A
FCF growth 5Y-22.21%
OCF growth 1Y120.88%
OCF growth 3YN/A
OCF growth 5Y-22.23%

XOMA ROYALTY CORP - XOMA 8 5/8 PERP / XOMAP Fundamental Analysis FAQ

What is the ChartMill fundamental rating of XOMA ROYALTY CORP - XOMA 8 5/8 PERP (XOMAP) stock?

ChartMill assigns a fundamental rating of 6 / 10 to XOMAP.


Can you provide the valuation status for XOMA ROYALTY CORP - XOMA 8 5/8 PERP?

ChartMill assigns a valuation rating of 5 / 10 to XOMA ROYALTY CORP - XOMA 8 5/8 PERP (XOMAP). This can be considered as Fairly Valued.


How profitable is XOMA ROYALTY CORP - XOMA 8 5/8 PERP (XOMAP) stock?

XOMA ROYALTY CORP - XOMA 8 5/8 PERP (XOMAP) has a profitability rating of 6 / 10.


What is the earnings growth outlook for XOMA ROYALTY CORP - XOMA 8 5/8 PERP?

The Earnings per Share (EPS) of XOMA ROYALTY CORP - XOMA 8 5/8 PERP (XOMAP) is expected to decline by -78.46% in the next year.


How sustainable is the dividend of XOMA ROYALTY CORP - XOMA 8 5/8 PERP (XOMAP) stock?

The dividend rating of XOMA ROYALTY CORP - XOMA 8 5/8 PERP (XOMAP) is 6 / 10 and the dividend payout ratio is 29.53%.